Ophthalmology is image-heavy, which has made the specialty accessible to telemedicine and the application of artificial intelligence, said Grayson Armstrong, MD, medical director of ophthalmic emergency services at Massachusetts Eye and Ear and instructor in ophthalmology at Harvard Medical School.
Ophthalmology is image-heavy, which has made the specialty accessible to telemedicine and the implementation of artificial intelligence (AI), said Grayson Armstrong, MD, medical director of ophthalmic emergency services at the Massachusetts Eye and Ear and instructor in ophthalmology at Harvard Medical School.
Transcription
You will be presenting on telemedicine and artificial intelligence for eye care at the AAO meeting. What are the key points you will talk about?
I’m incredibly excited to talk about telemedicine and AI at this upcoming AAO meeting. Ophthalmology as a specialty lends itself incredibly to the implementation of telemedicine and AI. We are an incredibly image-heavy specialty. We have lots of images and lots of data that make this possible. We are always at the cutting edge of technology. And we are, in many ways, the first to adopt them across all of medicine, across pharmacy, technology, innovation and AI.
A few of the conferences I will be speaking at – the first is called “Innovations in Telemedicine and AI from Around the World”, where I will be on a panel with Michael Chiang, MD, Director of the National Eye Institute, and also Daniel Shu Wei Ting from the National University of Singapore, where we talk about how to implement new technologies and AI in clinics with your patients. This is mainly for young ophthalmologists, but anyone can attend. It’s about where we are now as a field, where we’re going, and how to use it in your daily practice.
We also talk about the integration of AI technology and patient care, in general. And the last session is called “Optimizing telemedicine and AI for international and national use”. It will be during the 11:30 a.m. to 12:45 p.m. session on Sunday. It coincides with the Parker Health Conference, where Jim Madara, MD, who is the CEO of the American Medical Association, also talks about technology for patient care. I think it’s going to be quite innovative to hear how someone in charge of an organization as large as WADA thinks about these things, and how that can be applied to the field of ophthalmology.
